ESTIMATED
05/14/2024
05/14/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.05 | -$0.05 | -$0.05 |
Q2 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
Q3 2024 | 0 | -$0.06 | -$0.06 | -$0.06 |
Q4 2024 | 0 | -$0.05 | -$0.05 | -$0.05 |
Q1 2025 | 0 | -$0.03 | -$0.03 | -$0.03 |
Q2 2025 | 0 | -$0.03 | -$0.03 | -$0.03 |
Q3 2025 | 0 | -$0.03 | -$0.03 | -$0.03 |
Q4 2025 | 0 | -$0.03 | -$0.03 | -$0.03 |
Asensus Surgical, Inc. last posted its earnings results on Tuesday, May 14th, 2024. The company reported $-0.07 earnings per share for the quarter, missing analysts' consensus estimates of $-0.05 by $0.02. The company had revenue of 1.12 M for the quarter and had revenue of 8.58 M for the year. Asensus Surgical, Inc. has generated $0 earnings per share over the last year ($-0.31 diluted earnings per share) and currently has a price-to-earnings ratio of -1.15. Asensus Surgical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/14/2024 | Q1 2024 | -$0.05 | -$0.08 | -0.03 | $1.20 M | $1.12 M | 03/21/2024 | Q4 2023 | -$0.05 | -$0.07 | -0.02 | $5.45 M | $5.43 M | 11/14/2023 | Q3 2023 | -$0.07 | -$0.07 | -0 | $1.09 M | 08/10/2023 | Q2 2023 | -$0.08 | -$0.09 | -0.01 | $1.08 M | 05/11/2023 | Q1 2023 | -$0.07 | -$0.09 | -0.02 | $1.60 M | $976,000 | 03/02/2023 | Q4 2022 | -$0.07 | -$0.08 | -0.01 | $3.49 M | $2.46 M | 11/10/2022 | Q3 2022 | -$0.07 | -$0.08 | -0.01 | $2.56 M | 08/08/2022 | Q2 2022 | -$0.08 | -$0.08 | -0 | $994,000 | 05/04/2022 | Q1 2022 | -$0.08 | -$0.08 | -0 | $1.07 M | 02/28/2022 | Q4 2021 | -$0.07 | -$0.07 | 0 | $1.51 M | $2.48 M | 11/03/2021 | Q3 2021 | -$0.06 | -$0.07 | -0.01 | $1.02 M | $2.57 M | 08/05/2021 | Q2 2021 | -$0.06 | -$0.06 | 0 | $1.63 M | $1.10 M | 05/11/2021 | Q1 2021 | -$0.07 | -$0.08 | -0.01 | $2.08 M | 03/11/2021 | Q4 2020 | -$0.11 | -$0.13 | -0.02 | $1.06 M | $1.11 M | 11/05/2020 | Q3 2020 | -$0.23 | -$0.15 | 0.08 | $766,500 | $814,000 | 08/05/2020 | Q2 2020 | -$0.38 | -$0.26 | 0.12 | $444,000 | $655,000 | 05/15/2020 | Q1 2020 | -$0.57 | $600,000 | 03/16/2020 | Q4 2019 | -$0.62 | -$0.69 | -0.07 | $3.91 M | $688,000 | 11/12/2019 | Q3 2019 | -$1.01 | -$5.55 | -4.54 | $4.86 M | $2.02 M | 08/08/2019 | Q2 2019 | -$1.21 | $3.64 M |
---|
A. Asensus Surgical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates.
A. The conference call for Asensus Surgical, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Asensus Surgical, Inc.'s latest earnings report can be read online.
A. Asensus Surgical, Inc. (AMEX:ASXC) has a recorded annual revenue of $8.58 M.
A. Asensus Surgical, Inc. (AMEX:ASXC) has a recorded net income of $8.58 M. Asensus Surgical, Inc. has generated $-0.31 earnings per share over the last four quarters.
A. Asensus Surgical, Inc. (AMEX:ASXC) has a price-to-earnings ratio of -1.15 and price/earnings-to-growth ratio is -0.1.